New scan could replace invasive test for Cushing's disease diagnosis
NCT ID NCT07108244
First seen Jun 27, 2026 · Last updated Jul 07, 2026 · Updated 2 times
Summary
This study compares a new, non-invasive PET-MRI scan to the standard invasive test (IPSS) for finding pituitary tumors in people with Cushing's disease. About 43 adults with confirmed Cushing's will get both tests to see which is more accurate. The goal is to make diagnosis safer and more precise.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CUSHING DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Erasmus University Medical Centre
Rotterdam, South Holland, 3015, Netherlands
-
University Hospital Basel
Basel, Canton of Basel-City, 4031, Switzerland
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a Dual-Action pill tame the tumor behind cushing disease?
- Cushing's disease study in western france withdrawn before starting
- New pill could tame hormone disorder Cushing's syndrome
- New PET scan aims to spot tiny brain tumors that standard MRI misses
- New PET scan could spot tiny brain tumors missed by MRI
- New scan could pinpoint hidden brain tumors in cushing patients